SCA Registry

Registry for Spinocerebellar Ataxies (SCA)

Background and aims

Spinocerebellar Ataxies (SCA) are autosomal dominant inherited ataxia diseases. The SCA Registry builds on the EUROSCA and RISCA cohort studies funded by the EU since 2004. It includes high-risk individuals and patients with manifest ataxia of all SCA genotypes including the more common polyglutamine SCAs (SCA1, SCA2, SCA3, SCA6).

The objectives of the SCA Registry are to characterise the natural progression of the disease, identify prognostic factors and develop new imaging and biochemical biomarkers. By including risk persons, special emphasis is given to the investigation of the pre-clinical phase of the disease. The studies conducted under the SCA Registry are an immediate preparation of ongoing and future treatment studies.

Further information and contact data are available here.

Principle Investigator: Prof. Dr. Thomas Klockgether
Status: multi centric, ongoing, recruiting active

Studienkoordination / Projektmanagement

Dr. Ilaria Anna Giordano
 ilaria_anna.giordano@ukb.uni-bonn.de
 +49 228 287-15750

Participating sites

Bonn

DZNE
Local principle investigator:

Prof. Dr. Thomas Klockgether
Local contact: 
+49 228 287-15726

Munich

DZNE
Friedrich-Baur-Institut an der Neurologischen Klinik

Local principle investigator: 
Prof. Dr. Thomas Klopstock​​​​​​​
Local contact: 
+49 089 4400-57400

Tübingen

DZNE
Universitätsklinikum Tübingen
-
Zentrum für Neurologie, Abteilung Neurodegenerative Erkrankungen
LLocal principle investigator:
Prof. Dr. Ludger Schoels
Local contact:
+49 7071 298-6529

Info-Hotline

Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)

Inform yourself on our website cookie-free. However, we would be pleased if you would allow us to use statistical cookies. Your browser settings regarding cookies are currently as follows:
More information can be found in our Privacy policy.